Cargando…
Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study
OBJECTIVE: This study aimed to compare the effectiveness and safety of oxcarbazepine (OXC) vs. levetiracetam (LEV) for treating infantile focal epilepsy in a longitudinal cohort study. METHODS: We enrolled 187 consecutive patients aged 2–24 months who received OXC or LEV as initial monotherapy; 161...
Autores principales: | Zhao, Binyang, Liao, Shuang, Zhong, Xuefei, Luo, Yuanyuan, Hong, Siqi, Cheng, Min, Zhang, Jie, Li, Tingsong, Jiang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198356/ https://www.ncbi.nlm.nih.gov/pubmed/35720076 http://dx.doi.org/10.3389/fneur.2022.909191 |
Ejemplares similares
-
Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis
por: Kharel, Sanjeev, et al.
Publicado: (2022) -
Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes
por: Suo, Gui-hai, et al.
Publicado: (2021) -
Comparison of Lamotrigine and Oxcarbazepine Monotherapy Among Chinese Adult Patients With Newly-Diagnosed Focal-Onset Epilepsy: A Prospective Observational Study
por: Chen, Yuncan, et al.
Publicado: (2022) -
Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open‐label, randomized study
por: Zhu, Haoyue, et al.
Publicado: (2022) -
Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
por: Yi, Jia-Qin, et al.
Publicado: (2023)